This is excellent – nice work Amir Safavi & team! HCC is a site where I worry our humility as a field, emphasis on need for level 1 evidence (which barely exists comparing any local modalities), & focus on toxicity (rib fractures no good, but local recurrence worse) has diminished

Original Article: Microplastics and Nanoplastics in Atheromas and Cardiovascular Events nej.md/3IrM6T8 Editorial: Plastics, Fossil Carbon, and the Heart nej.md/48CvGSs #PublicHealth

Dr. Davis of the MI Rad Soc testifies against MI #SB279, an NP Scope of Practice expansion bill that bestows Nurse Practitioners the right to instantly & independently “order, perform, supervise, and INTERPRET imaging studies” through legislation, not education. #StopScopeCreep

New in IJROBP - The Red Journal: Phase II trial shows the rate of implant failure in reconstructed pts with #breastCancer treated with IMRT was similar to, but not improved over, conventional, 3D-conformal #radiation. #bcsm serial MRIs may detect early capsular contracture sciencedirect.com/science/articl…

New in Journal of Clinical Oncology: ASCO MASCC International Society of Oral Oncology (ISOO) multidisciplinary evidence-based recommendations for prevention and management of #osteoradionecrosis (#ORN) of the jaw secondary to head & neck #radiation therapy in patients with cancer. #hncsm #radonc ascopubs.org/doi/full/10.12…

Check out our new #Yonsei paper on 5fx ablative RT for primary breast tumors.🇰🇷🇨🇦 Excited for BC Cancer's upcoming SABR-PRIMeR trial led by Andrew Bang.📢More attention should be paid to these breast SABR (-ish) approaches in stage IV BC. ejbc.kr/DOIx.php?id=10…

Patients affected by para-aortic disease might have a PFS comparable to pelvic ones; LC is high in both cohorts. Our results also support the use of #SBRT for para-aortic #oligometastases

PRESS RELEASE: NRG Oncology Abstract Considered “Best of ASCO” for 2024 Shows Difference in Outcomes for Node-Negative Versus Node-Positive Pancreatic Cancer Patients when Adding Chemoradiation to Systemic Therapy - Read the release: ow.ly/6K0o50S8Nwf

A new #RedJournal special issue has published, PENTEC: Pediatric Normal Tissue Effects in the Clinic. This special issue represents years of work researching and writing critical reviews about the treatment of childhood cancers. ow.ly/OQoa50S7IFN

Burnout & moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful. In Search of Joy and Meaning in Modern Medicine JCO Oncology Practice ascopubs.org/doi/pdf/10.120…

On happiness…

Review on how to use of radiation for treatment of arthritis, was great to work on this with Matt Spraker Jason Beckta James Yu Dr. Brower, and Dr. Grew now available in PRO: sciencedirect.com/science/articl…

🔥NRG Oncology dose escalated #radonc contouring atlas for inoperable #pancreaticcancer in press!🔥 ➡️Step-by-step recs for anatomically derived CTV ➡️Dose escalation strategies suggested ➡️Will be reference for upcoming ph3 NRG GI011 trial that requires CTV redjournal.org/article/S0360-…

‼️ EUROPA interim Ph3 RCT 70+ y/o low risk breast cancer -> BCS -> adjuvant endocrine only vs adjuvant APBI only APBI has better HRQoL than endocrine tx, adj mean difference 6.39 (0.14-12.65) 0 IBTR, LRR, or DM events!! 🤩 #SABCS24

☢️💊💉Trimodality therapy offers hope for recurrent T1 bladder cancer after BCG failure! ✅ 3-year freedom from cystectomy: 88% ✅ 3-year OS: 69% ✅Distant metastasis at 3 years: 12% An alternative to radical cystectomy, but safety monitoring is key. #BladderCancer #Oncology

Phase II study The Lancet Oncology for unresectable stage III NSCLC: SBRT to primary then chemoradiation to nodes then durvalumab. 1y PFS 63% does not meet primary endpoint but favorable efficacy & safety vs historic standards. Phase III NRG LU008 underway. thelancet.com/journals/lanon…

Excellent review - Management of hepatocellular cancer ascopubs.org/doi/10.1200/OP… JCO Oncology Practice OncoAlert Ryan Nipp, MD, MPH, MBA, FASCO ASCO

#ESTRO25 Press release:  Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for #ProstateCancer, After 10-Year Follow-Up in Phase III Trial. 👉 bit.ly/3RNnw3B

How to decide PMRT in pT3NoMo Magee Equations score Clinicopathological factors (tumor size, grade, ER, PR, HER2, and Ki67) If score <18 no benefit with PMRT Safely Omit PMRT If score >18 [ no PMRT group had a higher LRR rate compared to the PMRT group ](11% vs. 2%; P =.01)

Interpreting liver mets on MRI can be challenging, in part b/c imaging features (hypo vs hypervascularity) vary by primary tumor site. I adapted this slide from Dr. Jim Apisarnthanarax presentation at ASTRO. Important for diagnosing & if treating w MR-guided RT.